Related Experiment Video
Updated: May 14, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Intracrine oestrogen production and action in breast cancer: an epigenetic focus
Kevin C Knower1, Sarah Q To, Colin D Clyne
1Cancer Drug Discovery, Prince Henry's Institute, Clayton, Victoria, Australia.
Abstract:
Epigenome changes have been widely demonstrated to contribute to the initiation and progression of a vast array of cancers including breast cancer. The reversible process of many epigenetic modifications is thus an attractive feature for the development of novel therapeutic measures. In oestrogen receptor α (hereinafter referred to as ER) positive tumours, endocrine therapies have proven beneficial in patient care, particularly in postmenopausal women where two-thirds of tumours are oestrogen dependent. However, resistance to such therapies is a common feature amongst individuals. In the current review, we discuss the influence that epigenetics has on oestrogen dependent breast cancers, in particular (i) the production of intracrine oestrogen in postmenopausal women, (ii) the action of oestrogen on epigenetic processes, and (iii) the links between epigenetics and endocrine resistance and the current advancements in epigenetic therapy that target this process. This article is part of a Special Issue entitled 'CSR 2013'.
Insights
Epigenetic modifications influence oestrogen receptor-positive breast cancer development and endocrine therapy resistance. Targeting these reversible epigenetic changes offers promising therapeutic strategies for breast cancer treatment.
Area of Science:
- Oncology
- Epigenetics
- Endocrinology
Background:
- Epigenome alterations are implicated in breast cancer initiation and progression.
- Endocrine therapies are effective for oestrogen receptor-positive (ER+) breast cancer, especially in postmenopausal women.
- Therapy resistance is a significant clinical challenge in ER+ breast cancer management.
Purpose of the Study:
- To review the role of epigenetics in oestrogen-dependent breast cancer.
- To discuss the influence of epigenetics on intracrine oestrogen production and oestrogen action.
- To explore the connection between epigenetics and endocrine resistance, and current epigenetic therapies.
Main Methods:
- Literature review focusing on epigenetics in breast cancer.
- Analysis of studies on oestrogen metabolism and epigenetic regulation.
- Examination of research on epigenetic mechanisms driving endocrine resistance.
Main Results:
- Epigenetic modifications impact intracrine oestrogen production in postmenopausal women.
- Oestrogen signaling influences epigenetic processes within breast cancer cells.
- Epigenetic alterations are linked to the development of resistance to endocrine therapies.
Conclusions:
- Epigenetics plays a critical role in oestrogen-dependent breast cancer and endocrine resistance.
- Reversible epigenetic modifications present viable targets for novel breast cancer therapies.
- Advancements in epigenetic therapy offer new avenues for overcoming endocrine resistance in breast cancer.
Related Concept Videos
Mitogens and the Cell Cycle
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
The Tumor Microenvironment
Oogenesis

